Seller record · Telehealth service
Lyfe RX
Fails 4 of 8 criteria. S2, prescription gating: Each compounded GLP-1 product page carries an add-to-cart button and lists the order as add to cart and check out first, then the medical intake, then the provider's review, and the terms say the medical intake form is completed immediately after checkout, with full payment at the time of purchase. The process page instead lists a quiz and a provider review before checkout. 3 more criteria also fail; see the table below.
At a glance
Lyfe RXTelehealth service
- Price
- Semaglutide $225, tirzepatide $299
- Sells
- compounded semaglutide (Compounded GLP-1), and 14 more
- FDA letters
- 1 on file
Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.
A Texas-based telehealth store selling compounded semaglutide and tirzepatide, sermorelin, NAD+, glutathione and PT-141 protocols, testosterone and sexual health prescriptions, and supplements and at-home lab panels. Its product pages take payment before the medical intake, and no pharmacy is named.
Operating entity Richie and Cindy Jaynes Enterprises Inc
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Lyfe RX's our providers page; Lyfe RX's website; Lyfe RX's terms and conditions |
| S2 | Prescription gating | FAIL | Lyfe RX's compounded GLP-1 product page; Lyfe RX's terms and conditions; Lyfe RX's the process page |
| S3 | Pharmacy identification | FAIL | Lyfe RX's compounded GLP-1 product page; Lyfe RX's the process page; Lyfe RX's terms and conditions |
| S4 | Compounding disclosure | PASS | Lyfe RX's compounded GLP-1 product page; Lyfe RX's compounded GIP GLP-1 product page; Lyfe RX's terms and conditions |
| S5 | Analytical documentation | FAIL | Lyfe RX's compounded GLP-1 product page; Lyfe RX's FAQ; Lyfe RX's terms and conditions |
| S6 | Business address | FAIL | Lyfe RX's contact page; Lyfe RX's terms and conditions; Lyfe RX's privacy policy |
| S7 | Price disclosure | PASS | Lyfe RX's website; Lyfe RX's compounded GIP GLP-1 product page; Lyfe RX's cancellation and refund policy |
| S8 | Enforcement status | PASS | FDA's website; letter to Lyfe Rx |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide (Compounded GLP-1), compounded tirzepatide (Compounded GIP/GLP-1), Lipo Burn lipotropic protocol, sermorelin troche, NAD+ injection, NAD+ nasal spray, glutathione, glutathione nasal spray, PT-141, GHK-Cu topical, testosterone therapy, oral testosterone (Kyzatrex), sildenafil, tadalafil, methylene blue.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141Who sells GHK-Cu
Enforcement documents on file: 1 warning letter
FDA warning letter without a number, issued September 2025, to Lyfe RxClaims on the website of clinically proven weight loss for compounded semaglutide and tirzepatide imply the products are the same as an approved drug, so they are false or misleading and misbrand the products.
A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.